Coherus Oncology (CHRS) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Coherus Oncology (CHRS) over the last 13 years, with Q3 2025 value amounting to -$19.07.
- Coherus Oncology's Times Interest Earned fell 1504.42% to -$19.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.69, marking a year-over-year increase of 6586.81%. This contributed to the annual value of -$4.11 for FY2024, which is 1796.28% up from last year.
- According to the latest figures from Q3 2025, Coherus Oncology's Times Interest Earned is -$19.07, which was down 1504.42% from -$19.98 recorded in Q2 2025.
- Coherus Oncology's 5-year Times Interest Earned high stood at $2.32 for Q4 2024, and its period low was -$29.63 during Q1 2021.
- Its 5-year average for Times Interest Earned is -$10.75, with a median of -$6.98 in 2023.
- The largest annual percentage gain for Coherus Oncology's Times Interest Earned in the last 5 years was 13580.62% (2024), contrasted with its biggest fall of 43173.33% (2024).
- Quarter analysis of 5 years shows Coherus Oncology's Times Interest Earned stood at -$6.83 in 2021, then grew by 19.63% to -$5.49 in 2022, then decreased by 18.26% to -$6.49 in 2023, then soared by 135.81% to $2.32 in 2024, then crashed by 920.69% to -$19.07 in 2025.
- Its last three reported values are -$19.07 in Q3 2025, -$19.98 for Q2 2025, and -$21.13 during Q1 2025.